Cambridge University Hospitals sits in the heart of the Cambridge Biomedical Campus and is part of the internationally renowned research campus which has seen a huge expansion over the last 20 years. The hospital is a partner in one of six designated academic health science centres, Cambridge University Health Partners, formed with Royal Papworth Hospital NHS Foundation Trust, Cambridgeshire and Peterborough NHS Foundation Trust and the University of Cambridge.
Research is central to the role and function of this specialist teaching hospital. In 2017, it was awarded £114 million from the National Institute for Health and Care Research (NIHR) to the Cambridge Biomedical Research Centre, a research partnership with the University of Cambridge. There are approximately 1,000 research studies underway at one time covering a range of health conditions including common conditions like diabetes and heart disease, through to specialist research in rare dementias and rare cancers.
The hospital has a number of high-specification facilities, equipment and resource to support all of this activity, including the recently expanded Cambridge Clinical Research Facilities offering 24/7 clinical beds to support Phase I and Phase II studies. In addition there is support to set up and initiate studies from the Cambridge Clinical Trials Unit, the Research & Development Department, the Cambridge BioResource and in processing and managing studies an onsite pharmacy and BioRepository.
Cambridge is one of 13 Genomic Medicine Centres, and the lead site for the East of England Genomic Medicine Centre, part of the 100,000 Genomes Project which is sequencing whole genomes of people with rare diseases and cancers.
